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Symptoms
Symptoms, as reported by individuals to
health providers, account for a high propor-
tion of medical encounters, and a surprising
majority are not explained by pathologic
medical conditions. Examples of such physi-
cal symptoms that after evaluation are found
to be without explanatory morphologic or
laboratory ﬁndings include headache, fatigue,
trouble concentrating, musculoskeletal symp-
toms, sleep problems, nausea, atypical chest
pain, and shortness of breath (1,2). Rather
than simply dismiss these unexplained symp-
toms or consider them as isolated symptoms,
over the past few decades, practitioners,
patients, and investigators have coalesced
these symptoms into syndromes, including
chronic fatigue syndrome (CFS), fibromyal-
gia (FM), chronic hypoglycemia, and irrita-
ble bowel syndrome. Similar and sometimes
almost overlapping groups of symptoms have
been delineated in the aftermath of a variety
of ongoing chemical or other environmental
exposures and include sick building syn-
drome (nonspecific building-related illness),
atypical connective tissue disease after sili-
cone breast implants, multiple chemical sen-
sitivities (MCS), and most recently Gulf War
syndrome and sensitivity to methyl tert-butyl
ether (MTBE) (3). Investigators have
pointed out the substantial overlap between
one unexplained symptom classification and
another, such that 30–50% of individuals
with CFS, FM, and MCS qualify (based on
self-reported symptoms) for at least one of
the other diagnoses, and substantial percent-
ages of those reporting illness after the Gulf
War have symptom complexes overlapping
with CFS and MCS (4–7). All are unex-
plained because despite many theories and
hypotheses, there is no acceptance by the
medical community of a demonstrated
pathology or etiology for the symptoms. For
Gulf War veterans, where the absence of
clinical pathology was explored with physical
and laboratory exams on a population rather
than case series basis, the absence of medical
explanation was most clearly demonstrated
without the biases inherent in selected sam-
ples (6). It is clearly impossible to accurately
estimate costs of all such conditions; how-
ever, expenditures on research and treatment
for all of these have been substantial. Limited
literature addresses productivity effects
related to indoor air (8,9). In its 1994 Indoor
Air Quality proposal, the Occupational
Safety and Health Administration estimated
the productivity costs associated with poor
indoor air quality at $15 billion (10).
Psychological/Psychiatric
Explanations
Psychiatric explanations and nomenclature
have less than a perfect ﬁt for many cases of
unexplained somatic symptoms, not with-
standing the signiﬁcant (sometimes >50% for
MCS and CFS) co-morbidity for anxiety
and/or depression (5,11). To complicate
assessments, some investigators have noted
that the number of symptoms an individual
reports is highly correlated with rates of anxi-
ety and depression (2). The purest psychiatric
diagnosis for an unexplained symptom syn-
drome is somatization disorder. However,
many individuals who qualify for CFS and
MCS do not qualify for somatization disorder
based on existing criteria, and furthermore,
variant definitions for somatization disorder
have been explored (5,12,13).
A growing literature documents the
association between environmental stimuli
and symptoms that are not known to be
organically based (14,15). The most widely
accepted example of this is that of post-
traumatic stress disorder (PTSD), in which
the experience of a traumatic environmental
event is a prerequisite for the diagnosis and is
the trigger for symptoms. PTSD has also
been associated with environmental chemical
exposures, as has the occurrence of other psy-
chiatric disorders such as anxiety and depres-
sion (15,16). The association between
environmental chemical exposures and unex-
plained physical symptoms, after adjusting for
psychiatric distress, has also been reported but
is less well accepted or understood (17).
Symptoms and 
the Environment
What is widely accepted, perhaps less so by
the public than by the scientiﬁc and especially
the mental health communities, is that there
are many other determinants of symptoms
than currently recognizable organic pathol-
ogy. This was clearly described by Anne
Spurgeon and her colleagues in a variant of
the biopsychosocial model shown in Figure 1,
which has two paths for symptoms, one
somatic (biological) and the other a combina-
tion of psychological and sociological (15).
Both paths are probably active in all individu-
als at all times, although new biological
knowledge or new social phenomena can
increase the relative importance attributed to
either side for a given problem.
This model allows for three different
elements to combine for the production of a
symptomatic state. The ﬁrst is a person with a
biomedical condition or susceptibility such as
airway hyperreactivity or vasomotor rhinitis.
The second element is an exposure to a
detectable, possibly irritating and/or odifer-
ous but not significantly tissue-damaging in
morphologic or biochemical terms, concen-
tration of a stimulus or toxin. The third ele-
ment is a person or group with one or more
personal or group psychosocial risk factors for
developing or reporting symptoms. With
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Unexplained Symptoms
Symptoms, and especially those without clear underlying medical explanations, account for a large
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these different elements interacting, it easy to
see how different groups of investigators (and
patients) differ as to on which side of a line of
discrimination (psychological vs. physical) the
various unexplained symptom syndromes
related to environment lie. As explained
above, there may also be more than one line,
and an individual may simultaneously be
appropriately characterized along more than
one seemingly orthogonal axis. Research must
help to sort out how we can simultaneously
evaluate the relative contributions of each of
the multiple paths to symptoms.
Neutra and colleagues considered this in a
series of reports that address the higher symp-
tom rates they observed around hazardous
waste sites in California (18–20). Prevalence
odds ratios for speciﬁc symptoms in exposed
versus unexposed populations were signifi-
cantly elevated more than 2-fold for 64% of
symptoms assessed in one study, with fatigue,
headache, poor sleep, nausea, chest pain, and
others sometimes showing odds in the 5- to
10-fold range (18). They considered possible
mechanisms for increased symptoms to
include classical toxicity, an immunological or
other physiogenic syndrome, behavioral sensi-
tization, psychosomatic reaction to stress,
mass psychogenic illness, reporting bias, con-
founding factors, or odor, as an effect modi-
fier. They noted the demonstrated excess of
symptoms in other situations (Three Mile
Island, anticipated insecticide spraying) where
exposure to toxic agents essentially did not
occur and the symptoms were, on reﬂection,
due to “environmental anxiety.” They con-
cluded for the dump sites that classical toxicity
was unlikely to explain the symptoms and
noted that many more symptoms occurred in
those who complained of odors in combina-
tion with having a high degree of “environ-
mental worry.” They felt it was possible that
autonomic, stress-mediated mechanisms or
behavioral sensitization could have been active
in the genesis of the symptoms. In a follow-up
analysis, Shusterman et al. (19) found an
interaction between environmental worry and
odor perception frequency, in addition to
their independent effects, such that headaches
were reported 38 times as often among those
with high worry and frequent odor percep-
tion. It was hypothesized that odors may serve
as a sensory cue for the manifestation of stress-
related illness or heightened awareness of
underlying symptoms among individuals con-
cerned about the quality of their neighbor-
hood environment. Experimental support for
an interaction between perception of chemical
odors and development of symptoms has been
reported: when a situation was manipulated to
suggest that an odor may be harmful, more
symptoms were reported by subjects than
when neutral or positive cues accompanied
the same odor in the same setting (21).
Epidemiology
A study published in the American Journal of
Epidemiology showed that symptoms associ-
ated with chemical sensitivity are fairly preva-
lent in the general population, are more
severe in asthmatic individuals, and have a
variable relationship to disability and medical
diagnosis (22). Very surprising were the mag-
nitude of the general prevalence of sensitivity
to chemicals (15%), the frequency of
reported physician diagnosis of MCS or envi-
ronmental illness (6%), and most surprising,
the relatively weak role of gender in deter-
mining symptoms and the very weak role of
socioeconomic status and race/ethnicity. The
use of the Centers for Disease Control and
Prevention’s rigorously conducted and ran-
domly sampled Behavioral Risk Factor
Surveillance interview series makes these data
highly reliable and generalizable. Another
recent study quantiﬁes an increased burden of
disability in Gulf War veterans meeting one
deﬁnition for MCS (23).
A number of recent investigations from
both the United States and the United
Kingdom have documented in well-designed
population-based studies that soldiers who
were deployed to the Gulf War zone experi-
enced 2 to 3 times the rate of symptoms as
comparable soldiers not deployed to the Gulf
War zone, and that there were no apparent
medically diagnosable conditions to explain
this symptomatology (6,24–26). Concern for
toxicologic causes of their symptoms remains
exceedingly high, as demonstrated by the
extensive mainstream press coverage in
October 1999 given to a RAND literature
review that concluded that pyridostigmine
bromide may have caused some of the symp-
toms (27). A recent study suggested an
increased risk for multiple symptoms among
those U.K. soldiers who received multiple vac-
cines during deployment but not for those sim-
ilarly vaccinated before deployment, perhaps
suggesting some interesting possibilities for
psychoneuroimmunological interactions (28).
Mechanistic Implications and
Complications
Ultimately, if we have experimentally vali-
dated mechanisms to explain the symptoms,
we will greatly advance our competence at
differential diagnosis, as well as opportunities
for prevention and treatment. Some investi-
gators are beginning to uncover potentially
relevant biological differences between those
who suffer with unexplained symptom syn-
dromes and those who do not. Among exam-
ples of this is the finding of elevated
substance P levels in the cerebrospinal ﬂuid of
those with clinical FM (29). Although all
behavior and symptomatology are at some
level grounded in physiologic brain function
at a neurochemical level, there still remain
useful and necessary distinctions, at least for
treatment if not etiology, between those con-
ditions clinically diagnosed dominantly by
behavior (e.g., depression, anxiety) and those
diagnosed dominantly by physiology (e.g.,
seizure disorders, multiple sclerosis) (30).
In a random sample of Californians, one
in five asthmatics reported being told by
his/her physician that he/she had environ-
mental illness or MCS; this is highly consis-
tent with previous studies suggesting that at
least the symptoms of people diagnosed with
the two conditions (asthma and MCS) are
often difficult to discriminate (31–33).
However, because for asthma we have reason-
ably well validated markers for the condition
(e.g., bronchial hyperreactivity as measured
by nonspecific challenge or by response to
bronchodilator medication), the differential
diagnosis is less vexing than with symptoms
such as fatigue, headache, or trouble concen-
trating. The last symptom is very common
and often seems severe and disabling. On the
basis of careful clinical study with neuro-
behavioral methods currently available, we
know that signiﬁcant and measurable neuro-
cognitive abnormalities do not accompany
the severe neurocognitive symptoms of most
with clinical MCS or CFS (5,34). It is
unlikely that investigators will find such
changes with similar methods in patients who
are less symptomatically afﬂicted than in the
rather extremely afflicted subjects studied in
these two groups.
An important study by Meggs et al. (35)
surveyed a random sample of rural North
Carolinians by telephone, and with a 71%
response rate found 35% reported sickness
after smelling chemical odors (chemical sensi-
tivity) and 35% reported sickness after
smelling “natural things” (allergy), with 16.9%
reporting both kinds of response. The respec-
tive roles of the concept of immunoglobulin E
allergy, irritancy, and airway (upper and lower)
reactivity in these percentages needs to be
apportioned in any adequate nosology of how
medically unexplained physical symptoms
relate to the environment.
Additionally, many more theories to
explain how individuals might become
sensitive to low levels of chemicals have been
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Figure 1. Modifiers of symptoms in occupational
and environmental syndromes. Adapted from
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advanced. Because human experimental data
are limited for all of them, they are not dis-
cussed extensively in the present report, but
excellent reviews are available (36,37).
Extensive discussions are beyond the scope
of the present article.
Challenges
In general, we still need accepted and
validated definition(s) for various presenta-
tions of symptomatic complaints stemming
from environmental exposures. Defining
severity and disability needs more focused
exploration. We rarely know what we are
looking at in biological terms. If some of
these symptoms are actually preferences to be
protected from certain olfactory stimuli
(scents) rather than documented pathology,
how do they fit into health? In a model
reliant on disease, they would not qualify.
However, if the broader World Health
Organization deﬁnition of health as complete
physical, mental, and social well-being is
used, such preferences might well become
drivers of preventive action (38). In the tradi-
tional paradigm of occupational and environ-
mental medicine, we were concerned with the
question, What is the cause of this illness?
The prevalence of medically unexplained
physical symptoms raises newer but more fre-
quently occurring and fundamental ques-
tions: Is this illness? What is the
apportionment of this illness between the
biological and the psychological? Speciﬁc rec-
ommendations are in the accompanying
review of the results of the conference (39).
Federal government health and research
agencies appear not to consider MCS and
other unexplained symptom conditions
(except perhaps CFS and more recently Gulf
War syndrome) as signiﬁcant priorities. After
years of effort, an interagency report on MCS
remains a predecisional draft, unissued (40).
These conditions are not powerful killers, and
frequently, because someone’s ox is being
gored by the concept of a cause for the condi-
tion, there is overt opposition to recognition
(deﬁnition) of the problem. This is, of course,
facilitated by the definitional difficulties
referred to above. On the other hand, the
potential for significant morbidity and eco-
nomic loss from symptoms such as those of
MCS, affecting 15% of a population of
school and working age, is huge (22).
Whether or not these conditions are “dis-
eases,” they represent signiﬁcant public health
problems and are often not readily distin-
guished from more clearly organic conditions.
The National Academy of Sciences and the
Institute of Medicine have convened a succes-
sion of committees to study unexplained
symptoms in terms of Gulf War issues. As
explained above, careful epidemiology shows
that, compared with soldiers who did not
deploy to the Persian Gulf, those who
deployed had 2- to 3-fold increases in symp-
toms, without apparent medical explanations
(6,26). However, we still do not have agree-
ment on what lies beneath these symptoms or
what path(s) mediate them. Clearly there is a
public health problem, and denial of its signiﬁ-
cance and magnitude will not bring us closer
to managing its consequences.
The following companion article (39) to
this introduction to the problem summarizes
the results of contributed papers and group
discussions raised in the present discussion.
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